Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAIbovine cardiac vascular active peptide; Double Proline AG 3D active collagen peptide; cartilage peptide, a type II collagen peptide; Se Plus tablets and sugar master tablets. The company was incorporated in 2019 and is based in Hudson, Ohio.